@FiercePharma: Analysts: Expect more hostile bids in pharma. Story | Follow @FiercePharma
> China's new rules on good manufacturing practices are likely to drive consolidation among the country's 5,000-plus pharmaceutical companies, especially the smaller firms, according to legal company Bird & Bird. News
> Boehringer Ingelheim saw net income slump by half in 2010 as cheaper generic copies of some of its best-selling pharmaceuticals came to market. Story
> Sanofi-Aventis has created the third largest generics company in Europe after re-branding its generic operations under the name Zentiva. Item
> AstraZeneca plans to invest 80 billion won ($73.7 million) in South Korea over the next five years to step up cooperation in the country's medical sector. Report
> Shares of Questcor Pharmaceuticals shot up in after-hours trading following the news of its higher-than-expected first-quarter sales forecast. Article
> Mylan Pharmaceuticals has won final FDA approval for its generic version of the Pfizer eye drop Xalatan. News
> Eli Lilly announced the availability of Axiron for testosterone deficiency in pharmacies across the U.S. Report
> BioMarin Pharmaceutical will not seek full rights to Aldurazyme, a drug marketed by partner Genzyme to treat a rare metabolic disease, following Monday's $20 billion acquisition of Genzyme by Sanofi-Aventis. Story
Biotech News
@FierceBiotech: 10 promising late-stage cancer drugs. Item | Follow @FierceBiotech
@JohnCFierce: Bavarian Nordic is raising $123M to finish development of Prostvac for prostate cancer. Story | Follow @JohnCFierce
> Blockbuster antibodies face a unique set of challenges. News
> VCs: Chill sets in on biotech as social networking gets hot. Article
> FDA panel readies pivotal review of Optimer's fidaxomicin. Report
> Bayer faces setback as Xarelto data highlights increased bleeding risk. Story
> Genzyme touts positive LDL data from mipomersen Ph3. News
Biotech Research News
> Coming soon: 3D adult stem cells, no glasses required. Article
> Nanoparticles provide protection against nickel allergies. News
> Israeli biotech Pluristem uses stem cells from placentas. Item
> Gene-patent courtroom drama plays out in Washington. Story
> Alzheimer's researchers have five new genes to ponder. Report
> Former football player now studies athletes' genes. Story
Manufacturing News
> DNA links Lilly, GSK warehouse thefts. Article
> PAT, QbD spur continuous processing. News
> Merck, Roche add voice to pick operations. Item
> McNeil consent decree quarantine helps J&J's bottom line. Report
> Roche, Catalent suffer warehouse fires. News
> India marks its fifth $1B drugmaker. Story
And Finally... A new hydration method for preventing kidney damage among patients who receive contrast agents during heart procedures was deemed more effective than the conventional way. Report